{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:10:41Z","timestamp":1792293041861,"version":"4.4.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":1328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA020912"],"award-info":[{"award-number":["AA020912"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA022538"],"award-info":[{"award-number":["AA022538"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s13311-019-00795-4","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T17:16:39Z","timestamp":1571159799000},"page":"4-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder"],"prefix":"10.1016","volume":"17","author":[{"given":"Kana","family":"Hamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7099-2442","authenticated-orcid":false,"given":"Amy W.","family":"Lasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1007\/s13311-019-00795-4_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"10152","key":"10.1007\/s13311-019-00795-4_bib2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"392","author":"Collaborators","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1007\/s13311-019-00795-4_bib3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.2018.11406","article-title":"Diagnosis and pharmacotherapy of alcohol use disorder: a review","volume":"320","author":"Kranzler","year":"2018","journal-title":"JAMA"},{"issue":"8","key":"10.1007\/s13311-019-00795-4_bib4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"10.1007\/s13311-019-00795-4_bib5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1007\/s13311-019-00795-4_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-018-0782-4","article-title":"Mechanisms of receptor tyrosine kinase activation in cancer","volume":"17","author":"Du","year":"2018","journal-title":"Mol Cancer"},{"key":"10.1007\/s13311-019-00795-4_bib7","doi-asserted-by":"crossref","unstructured":"Yamaoka, T., et al., Receptor tyrosine kinase-targeted cancer therapy. Int J Mol Sci, 2018. 19(11).","DOI":"10.3390\/ijms19113491"},{"issue":"4","key":"10.1007\/s13311-019-00795-4_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrn1078","article-title":"Neurotrophins and their receptors: a convergence point for many signalling pathways","volume":"4","author":"Chao","year":"2003","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"10.1007\/s13311-019-00795-4_bib9","doi-asserted-by":"crossref","first-page":"10122","DOI":"10.3390\/ijms140510122","article-title":"TrkB receptor signalling: implications in neurodegenerative, psychiatric and proliferative disorders","volume":"14","author":"Gupta","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s13311-019-00795-4_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.semcdb.2015.10.003","article-title":"Dysregulated fibroblast growth factor (FGF) signaling in neurological and psychiatric disorders","volume":"53","author":"Turner","year":"2016","journal-title":"Semin Cell Dev Biol"},{"issue":"5","key":"10.1007\/s13311-019-00795-4_bib11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0896-6273(92)90209-V","article-title":"The trkB tyrosine protein kinase is a receptor for neurotrophin-4","volume":"8","author":"Klein","year":"1992","journal-title":"Neuron"},{"issue":"2","key":"10.1007\/s13311-019-00795-4_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0092-8674(91)90628-C","article-title":"The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3","volume":"66","author":"Klein","year":"1991","journal-title":"Cell"},{"issue":"4","key":"10.1007\/s13311-019-00795-4_bib13","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1242\/dev.109.4.845","article-title":"Expression of the tyrosine kinase receptor gene trkB is confined to the murine embryonic and adult nervous system","volume":"109","author":"Klein","year":"1990","journal-title":"Development"},{"issue":"1","key":"10.1007\/s13311-019-00795-4_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0092-8674(05)80088-1","article-title":"Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death","volume":"75","author":"Klein","year":"1993","journal-title":"Cell"},{"key":"10.1007\/s13311-019-00795-4_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-642-45106-5_5","article-title":"Trk receptors","volume":"220","author":"Deinhardt","year":"2014","journal-title":"Handb Exp Pharmacol"},{"issue":"Pt A","key":"10.1007\/s13311-019-00795-4_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainres.2015.03.025","article-title":"Corticostriatal BDNF and alcohol addiction","volume":"1628","author":"Logrip","year":"2015","journal-title":"Brain Res"},{"issue":"4","key":"10.1007\/s13311-019-00795-4_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4103\/0976-500X.119712","article-title":"Expression of cFos and brain-derived neurotrophic factor in cortex and hippocampus of ethanol-withdrawn male and female rats","volume":"4","author":"Alele","year":"2013","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1007\/s13311-019-00795-4_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuroscience.2013.09.031","article-title":"Chronic binge-like alcohol consumption in adolescence causes depression-like symptoms possibly mediated by the effects of BDNF on neurogenesis","volume":"254","author":"Briones","year":"2013","journal-title":"Neuroscience"},{"issue":"5","key":"10.1007\/s13311-019-00795-4_bib19","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1471-4159.2009.06073.x","article-title":"Escalating ethanol intake is associated with altered corticostriatal BDNF expression","volume":"109","author":"Logrip","year":"2009","journal-title":"J Neurochem"},{"issue":"2","key":"10.1007\/s13311-019-00795-4_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0304-3940(95)11922-J","article-title":"Chronic ethanol administration decreases brain-derived neurotrophic factor gene expression in the rat hippocampus","volume":"197","author":"MacLennan","year":"1995","journal-title":"Neurosci Lett"},{"issue":"46","key":"10.1007\/s13311-019-00795-4_bib21","doi-asserted-by":"crossref","first-page":"10542","DOI":"10.1523\/JNEUROSCI.3714-04.2004","article-title":"RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction","volume":"24","author":"McGough","year":"2004","journal-title":"J Neurosci"},{"issue":"1","key":"10.1007\/s13311-019-00795-4_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.expneurol.2004.05.026","article-title":"Repeated episodic exposure to ethanol affects neurotrophin content in the forebrain of the mature rat","volume":"189","author":"Miller","year":"2004","journal-title":"Exp Neurol"},{"issue":"4","key":"10.1007\/s13311-019-00795-4_bib23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/neu.20059","article-title":"Chronic exposure to ethanol alters neurotrophin content in the basal forebrain-cortex system in the mature rat: effects on autocrine-paracrine mechanisms","volume":"60","author":"Miller","year":"2004","journal-title":"J Neurobiol"},{"issue":"9","key":"10.1007\/s13311-019-00795-4_bib24","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1007\/s00429-015-1163-z","article-title":"Alcohol dependence-induced regulation of the proliferation and survival of adult brain progenitors is associated with altered BDNF-TrkB signaling","volume":"221","author":"Somkuwar","year":"2016","journal-title":"Brain Struct Funct"},{"issue":"2","key":"10.1007\/s13311-019-00795-4_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/1097-4547(20010115)63:2<200::AID-JNR1012>3.0.CO;2-Q","article-title":"Effects of alcohol on brain-derived neurotrophic factor mRNA expression in discrete regions of the rat hippocampus and hypothalamus","volume":"63","author":"Tapia-Arancibia","year":"2001","journal-title":"J Neurosci Res"},{"issue":"2","key":"10.1007\/s13311-019-00795-4_bib26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1369-1600.2010.00275.x","article-title":"The role of amygdaloid brain-derived neurotrophic factor, activity-regulated cytoskeleton-associated protein and dendritic spines in anxiety and alcoholism","volume":"16","author":"Moonat","year":"2011","journal-title":"Addict Biol"},{"issue":"8","key":"10.1007\/s13311-019-00795-4_bib27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.biopsych.2013.01.012","article-title":"Aberrant histone deacetylase2-mediated histone modifications and synaptic plasticity in the amygdala predisposes to anxiety and alcoholism","volume":"73","author":"Moonat","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"43","key":"10.1007\/s13311-019-00795-4_bib28","doi-asserted-by":"crossref","first-page":"13494","DOI":"10.1523\/JNEUROSCI.2243-09.2009","article-title":"Endogenous BDNF in the dorsolateral striatum gates alcohol drinking","volume":"29","author":"Jeanblanc","year":"2009","journal-title":"J Neurosci"},{"issue":"2","key":"10.1007\/s13311-019-00795-4_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1017\/S1461145713001144","article-title":"Reversal of deficits in dendritic spines, BDNF and Arc expression in the amygdala during alcohol dependence by HDAC inhibitor treatment","volume":"17","author":"You","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"issue":"10","key":"10.1007\/s13311-019-00795-4_bib30","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1523\/JNEUROSCI.4752-07.2008","article-title":"Effector immediate-early gene arc in the amygdala plays a critical role in alcoholism","volume":"28","author":"Pandey","year":"2008","journal-title":"J Neurosci"},{"issue":"4","key":"10.1007\/s13311-019-00795-4_bib31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/ejn.12067","article-title":"BDNF-mediated regulation of ethanol consumption requires the activation of the MAP kinase pathway and protein synthesis","volume":"37","author":"Jeanblanc","year":"2013","journal-title":"Eur J Neurosci"},{"issue":"5","key":"10.1007\/s13311-019-00795-4_bib32","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1046\/j.1471-4159.2003.01748.x","article-title":"Ethanol consumption and serotonin-1A (5-HT1A) receptor function in heterozygous BDNF (+\/-) mice","volume":"85","author":"Hensler","year":"2003","journal-title":"J Neurochem"},{"issue":"5","key":"10.1007\/s13311-019-00795-4_bib33","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1523\/JNEUROSCI.3786-05.2006","article-title":"The dopamine D3 receptor is part of a homeostatic pathway regulating ethanol consumption","volume":"26","author":"Jeanblanc","year":"2006","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00795-4_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2018.07.031","article-title":"Increasing Brain-derived neurotrophic factor (BDNF) in medial prefrontal cortex selectively reduces excessive drinking in ethanol dependent mice","volume":"140","author":"Haun","year":"2018","journal-title":"Neuropharmacology"},{"issue":"32","key":"10.1007\/s13311-019-00795-4_bib35","doi-asserted-by":"crossref","first-page":"8320","DOI":"10.1523\/JNEUROSCI.4988-05.2006","article-title":"Central and medial amygdaloid brain-derived neurotrophic factor signaling plays a critical role in alcohol-drinking and anxiety-like behaviors","volume":"26","author":"Pandey","year":"2006","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00795-4_bib36","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.nbd.2015.03.019","article-title":"Potential role of adolescent alcohol exposure-induced amygdaloid histone modifications in anxiety and alcohol intake during adulthood","volume":"82","author":"Pandey","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1007\/s13311-019-00795-4_bib37","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1530-0277.2008.00650.x","article-title":"Innate differences in the expression of brain-derived neurotrophic factor in the regions within the extended amygdala between alcohol preferring and nonpreferring rats","volume":"32","author":"Prakash","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"10.1007\/s13311-019-00795-4_bib38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.biopsych.2015.06.007","article-title":"The BDNF valine 68 to methionine polymorphism increases compulsive alcohol drinking in mice that is reversed by tropomyosin receptor kinase B activation","volume":"79","author":"Warnault","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1007\/s13311-019-00795-4_bib39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/mp.2014.38","article-title":"Ethanol-induced epigenetic regulations at the Bdnf gene in C57BL\/6 J mice","volume":"20","author":"Stragier","year":"2015","journal-title":"Mol Psychiatry"},{"issue":"8","key":"10.1007\/s13311-019-00795-4_bib40","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1038\/npp.2014.51","article-title":"Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone","volume":"39","author":"Leggio","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1007\/s13311-019-00795-4_bib41","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/adb.12358","article-title":"Anaplastic lymphoma kinase regulates binge-like drinking and dopamine receptor sensitivity in the ventral tegmental area","volume":"22","author":"Dutton","year":"2017","journal-title":"Addict Biol"},{"issue":"36","key":"10.1007\/s13311-019-00795-4_bib42","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1523\/JNEUROSCI.0890-17.2017","article-title":"Fibroblast growth factor 2 in the dorsomedial striatum is a novel positive regulator of alcohol consumption","volume":"37","author":"Even-Chen","year":"2017","journal-title":"J Neurosci"},{"issue":"5","key":"10.1007\/s13311-019-00795-4_bib43","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.cell.2009.03.020","article-title":"Happyhour, a Ste20 family kinase, implicates EGFR signaling in ethanol-induced behaviors","volume":"137","author":"Corl","year":"2009","journal-title":"Cell"},{"key":"10.1007\/s13311-019-00795-4_bib44","doi-asserted-by":"crossref","unstructured":"Even-Chen, O. and S. Barak, Inhibition of FGF receptor-1 suppresses alcohol consumption: role of PI3 kinase signaling in dorsomedial striatum. J Neurosci, 2019.","DOI":"10.1523\/JNEUROSCI.0805-19.2019"},{"issue":"39","key":"10.1007\/s13311-019-00795-4_bib45","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1523\/JNEUROSCI.4597-14.2016","article-title":"The neurotrophic factor receptor p75 in the rat dorsolateral striatum drives excessive alcohol drinking","volume":"36","author":"Darcq","year":"2016","journal-title":"J Neurosci"},{"issue":"6","key":"10.1007\/s13311-019-00795-4_bib46","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.tpj.6500430","article-title":"Nucleotide sequence variation within the human tyrosine kinase B neurotrophin receptor gene: association with antisocial alcohol dependence","volume":"7","author":"Xu","year":"2007","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"10.1007\/s13311-019-00795-4_bib47","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/ADM.0000000000000277","article-title":"COMT and BDNF gene variants help to predict alcohol consumption in alcohol-dependent patients","volume":"11","author":"Klimkiewicz","year":"2017","journal-title":"J Addict Med"},{"issue":"4","key":"10.1007\/s13311-019-00795-4_bib48","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1530-0277.2008.00886.x","article-title":"Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence","volume":"33","author":"Wojnar","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1007\/s13311-019-00795-4_bib49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pnpbp.2012.09.005","article-title":"Brain-derived neurotrophic factor Val66Met polymorphism and alcohol-related phenotypes","volume":"40","author":"Nedic","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1007\/s13311-019-00795-4_bib50","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S1734-1140(10)70354-6","article-title":"Family-based study of brain-derived neurotrophic factor (BDNF) gene polymorphism in alcohol dependence","volume":"62","author":"Grzywacz","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1007\/s13311-019-00795-4_bib51","doi-asserted-by":"crossref","unstructured":"Silva-Pena, D., et al., Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats. Addict Biol, 2018.","DOI":"10.1111\/adb.12668"},{"issue":"6","key":"10.1007\/s13311-019-00795-4_bib52","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.pnpbp.2010.05.025","article-title":"BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal","volume":"34","author":"Heberlein","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"11","key":"10.1007\/s13311-019-00795-4_bib53","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41398-017-0015-4","article-title":"ProBDNF\/p75NTR\/sortilin pathway is activated in peripheral blood of patients with alcohol dependence","volume":"7","author":"Zhou","year":"2018","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1007\/s13311-019-00795-4_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41398-019-0367-z","article-title":"The lncRNA BDNF-AS is an epigenetic regulator in the human amygdala in early onset alcohol use disorders","volume":"9","author":"Bohnsack","year":"2019","journal-title":"Transl Psychiatry"},{"issue":"3","key":"10.1007\/s13311-019-00795-4_bib55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrd3366","article-title":"Potential therapeutic uses of BDNF in neurological and psychiatric disorders","volume":"10","author":"Nagahara","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1007\/s13311-019-00795-4_bib56","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1073\/pnas.0913572107","article-title":"A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone","volume":"107","author":"Jang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-019-00795-4_bib57","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neulet.2014.02.058","article-title":"7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis","volume":"566","author":"Korkmaz","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-019-00795-4_bib58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pbb.2014.03.013","article-title":"Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia","volume":"122","author":"Yang","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1007\/s13311-019-00795-4_bib59","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1073\/pnas.1718683115","article-title":"The prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer's disease","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1007\/s13311-019-00795-4_bib60","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn812","article-title":"The GDNF family: signalling, biological functions and therapeutic value","volume":"3","author":"Airaksinen","year":"2002","journal-title":"Nat Rev Neurosci"},{"issue":"6461","key":"10.1007\/s13311-019-00795-4_bib61","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/367380a0","article-title":"Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret","volume":"367","author":"Schuchardt","year":"1994","journal-title":"Nature"},{"issue":"6586","key":"10.1007\/s13311-019-00795-4_bib62","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/382073a0","article-title":"Defects in enteric innervation and kidney development in mice lacking GDNF","volume":"382","author":"Pichel","year":"1996","journal-title":"Nature"},{"issue":"6585","key":"10.1007\/s13311-019-00795-4_bib63","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/381789a0","article-title":"GDNF signalling through the Ret receptor tyrosine kinase","volume":"381","author":"Durbec","year":"1996","journal-title":"Nature"},{"issue":"24 Pt A","key":"10.1007\/s13311-019-00795-4_bib64","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1016\/j.febslet.2015.11.006","article-title":"GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease","volume":"589","author":"Kramer","year":"2015","journal-title":"FEBS Lett"},{"issue":"5111","key":"10.1007\/s13311-019-00795-4_bib65","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science"},{"issue":"12","key":"10.1007\/s13311-019-00795-4_bib66","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1242\/dev.126.12.2785","article-title":"Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system","volume":"126","author":"Taraviras","year":"1999","journal-title":"Development"},{"issue":"1","key":"10.1007\/s13311-019-00795-4_bib67","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0304-3940(94)90218-6","article-title":"Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo","volume":"182","author":"Hoffer","year":"1994","journal-title":"Neurosci Lett"},{"issue":"6512","key":"10.1007\/s13311-019-00795-4_bib68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/373335a0","article-title":"Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo","volume":"373","author":"Tomac","year":"1995","journal-title":"Nature"},{"issue":"9","key":"10.1007\/s13311-019-00795-4_bib69","doi-asserted-by":"crossref","first-page":"e2359","DOI":"10.1038\/cddis.2016.263","article-title":"Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model","volume":"7","author":"Drinkut","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1007\/s13311-019-00795-4_bib70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuropharm.2018.05.014","article-title":"GDNF revisited: a novel mammalian cell-derived variant form of GDNF increases dopamine turnover and improves brain biodistribution","volume":"147","author":"Grondin","year":"2019","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1007\/s13311-019-00795-4_bib71","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1523\/JNEUROSCI.3959-04.2005","article-title":"Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption","volume":"25","author":"He","year":"2005","journal-title":"J Neurosci"},{"issue":"2","key":"10.1007\/s13311-019-00795-4_bib72","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0031-6997(25)06842-5","article-title":"100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug","volume":"47","author":"Popik","year":"1995","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1007\/s13311-019-00795-4_bib73","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1369-1600.2010.00251.x","article-title":"Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration","volume":"15","author":"Carnicella","year":"2010","journal-title":"Addict Biol"},{"issue":"2","key":"10.1007\/s13311-019-00795-4_bib74","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1124\/jpet.102.039875","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)\/alpha(2)-adrenoceptor","volume":"303","author":"Newman-Tancredi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1007\/s13311-019-00795-4_bib75","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biopsych.2008.12.022","article-title":"Cabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor","volume":"66","author":"Carnicella","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"23","key":"10.1007\/s13311-019-00795-4_bib76","doi-asserted-by":"crossref","first-page":"8114","DOI":"10.1073\/pnas.0711755105","article-title":"GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse","volume":"105","author":"Carnicella","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1007\/s13311-019-00795-4_bib77","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.alcohol.2008.12.001","article-title":"Excessive alcohol consumption is blocked by glial cell line-derived neurotrophic factor","volume":"43","author":"Carnicella","year":"2009","journal-title":"Alcohol"},{"key":"10.1007\/s13311-019-00795-4_bib78","doi-asserted-by":"crossref","unstructured":"Barak, S., et al., Positive autoregulation of GDNF levels in the ventral tegmental area mediates long-lasting inhibition of excessive alcohol consumption. Transl Psychiatry, 2011. 1.","DOI":"10.1038\/tp.2011.57"},{"issue":"13","key":"10.1007\/s13311-019-00795-4_bib79","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1096\/fj.06-6394fje","article-title":"Autoregulation of glial cell line-derived neurotrophic factor expression: implications for the long-lasting actions of the anti-addiction drug, Ibogaine","volume":"20","author":"He","year":"2006","journal-title":"FASEB J"},{"issue":"27","key":"10.1007\/s13311-019-00795-4_bib80","doi-asserted-by":"crossref","first-page":"9885","DOI":"10.1523\/JNEUROSCI.1750-11.2011","article-title":"Glial cell line-derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: implications for alcohol reward and seeking","volume":"31","author":"Barak","year":"2011","journal-title":"J Neurosci"},{"issue":"6","key":"10.1007\/s13311-019-00795-4_bib81","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1530-0277.2009.00922.x","article-title":"GDNF is an endogenous negative regulator of ethanol-mediated reward and of ethanol consumption after a period of abstinence","volume":"33","author":"Carnicella","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"issue":"11","key":"10.1007\/s13311-019-00795-4_bib82","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nn734","article-title":"GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons","volume":"4","author":"Yang","year":"2001","journal-title":"Nat Neurosci"},{"issue":"43","key":"10.1007\/s13311-019-00795-4_bib83","doi-asserted-by":"crossref","first-page":"14502","DOI":"10.1523\/JNEUROSCI.3909-10.2010","article-title":"Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system","volume":"30","author":"Wang","year":"2010","journal-title":"J Neurosci"},{"issue":"2","key":"10.1007\/s13311-019-00795-4_bib84","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0165-3806(99)00171-6","article-title":"Glial-derived neurotrophic factor (GDNF) prevents ethanol-induced apoptosis and JUN kinase phosphorylation","volume":"119","author":"McAlhany","year":"2000","journal-title":"Brain Res Dev Brain Res"},{"issue":"1-3","key":"10.1007\/s13311-019-00795-4_bib85","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainresbull.2006.08.014","article-title":"Glial-derived neurotrophic factor (GDNF) prevents ethanol (EtOH) induced B92 glial cell death by both PI3K\/AKT and MEK\/ERK signaling pathways","volume":"71","author":"Villegas","year":"2006","journal-title":"Brain Res Bull"},{"issue":"4","key":"10.1007\/s13311-019-00795-4_bib86","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/adb.12028","article-title":"GDNF is a novel ethanol-responsive gene in the VTA: implications for the development and persistence of excessive drinking","volume":"19","author":"Ahmadiantehrani","year":"2014","journal-title":"Addict Biol"},{"key":"10.1007\/s13311-019-00795-4_bib87","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fphar.2017.00365","article-title":"A novel small molecule GDNF receptor RET agonist, BT13, promotes neurite growth from sensory neurons in vitro and attenuates experimental neuropathy in the rat","volume":"8","author":"Sidorova","year":"2017","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1007\/s13311-019-00795-4_bib88","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1021\/acsomega.7b01932","article-title":"Small-molecule ligands as potential GDNF family receptor agonists","volume":"3","author":"Ivanova","year":"2018","journal-title":"ACS Omega"},{"issue":"5151","key":"10.1007\/s13311-019-00795-4_bib89","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"issue":"4","key":"10.1007\/s13311-019-00795-4_bib90","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/1568009615666150225123712","article-title":"A pan-cancer review of ALK mutations: implications for carcinogenesis and therapy","volume":"15","author":"Yau","year":"2015","journal-title":"Curr Cancer Drug Targets"},{"issue":"360","key":"10.1007\/s13311-019-00795-4_bib91","doi-asserted-by":"crossref","first-page":"ra6","DOI":"10.1126\/scisignal.2005916","article-title":"Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK","volume":"8","author":"Murray","year":"2015","journal-title":"Sci Signal"},{"issue":"52","key":"10.1007\/s13311-019-00795-4_bib92","doi-asserted-by":"crossref","first-page":"15862","DOI":"10.1073\/pnas.1520099112","article-title":"Augmentor alpha and beta (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: hierarchy and specificity of ligand-receptor interactions","volume":"112","author":"Reshetnyak","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"10.1007\/s13311-019-00795-4_bib93","doi-asserted-by":"crossref","first-page":"16772","DOI":"10.1074\/jbc.M010660200","article-title":"Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin","volume":"276","author":"Stoica","year":"2001","journal-title":"J Biol Chem"},{"issue":"39","key":"10.1007\/s13311-019-00795-4_bib94","doi-asserted-by":"crossref","first-page":"35990","DOI":"10.1074\/jbc.M205749200","article-title":"Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types","volume":"277","author":"Stoica","year":"2002","journal-title":"J Biol Chem"},{"issue":"39","key":"10.1007\/s13311-019-00795-4_bib95","doi-asserted-by":"crossref","first-page":"28683","DOI":"10.1074\/jbc.M704505200","article-title":"Anaplastic lymphoma kinase is activated through the pleiotrophin\/receptor protein-tyrosine phosphatase beta\/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation","volume":"282","author":"Perez-Pinera","year":"2007","journal-title":"J Biol Chem"},{"issue":"18","key":"10.1007\/s13311-019-00795-4_bib96","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1074\/jbc.274.18.12474","article-title":"A receptor-like protein-tyrosine phosphatase PTPzeta\/RPTPbeta binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPzeta","volume":"274","author":"Maeda","year":"1999","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1007\/s13311-019-00795-4_bib97","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.bbapap.2013.06.004","article-title":"Anaplastic lymphoma kinase: \u201cligand independent activation\u201d mediated by the PTN\/RPTPbeta\/zeta signaling pathway","volume":"1834","author":"Deuel","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1007\/s13311-019-00795-4_bib98","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sj.npp.1301446","article-title":"Behavioral and neurochemical alterations in mice deficient in anaplastic lymphoma kinase suggest therapeutic potential for psychiatric indications","volume":"33","author":"Bilsland","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1007\/s13311-019-00795-4_bib99","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.pbb.2011.10.024","article-title":"Anaplastic lymphoma kinase and leukocyte tyrosine kinase: functions and genetic interactions in learning, memory and adult neurogenesis","volume":"100","author":"Weiss","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"10.1007\/s13311-019-00795-4_bib100","doi-asserted-by":"crossref","first-page":"e0123542","DOI":"10.1371\/journal.pone.0123542","article-title":"Targeted disruption of ALK reveals a potential role in hypogonadotropic hypogonadism","volume":"10","author":"Witek","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1007\/s13311-019-00795-4_bib101","doi-asserted-by":"crossref","first-page":"e22636","DOI":"10.1371\/journal.pone.0022636","article-title":"An evolutionary conserved role for anaplastic lymphoma kinase in behavioral responses to ethanol","volume":"6","author":"Lasek","year":"2011","journal-title":"PLoS One"},{"key":"10.1007\/s13311-019-00795-4_bib102","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fphar.2017.00533","article-title":"Anaplastic lymphoma kinase is a regulator of alcohol consumption and excitatory synaptic plasticity in the nucleus accumbens shell","volume":"8","author":"Mangieri","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1007\/s13311-019-00795-4_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2016.03.003","article-title":"Dependence-induced ethanol drinking and GABA neurotransmission are altered in Alk deficient mice","volume":"107","author":"Schweitzer","year":"2016","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1007\/s13311-019-00795-4_bib104","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jpsychires.2011.06.005","article-title":"A meta-analysis of two genome-wide association studies identifies 3 new loci for alcohol dependence","volume":"45","author":"Wang","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.1007\/s13311-019-00795-4_bib105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuropharm.2017.01.013","article-title":"Synaptic targets: chronic alcohol actions","volume":"122","author":"Roberto","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-019-00795-4_bib106","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neuropharm.2018.04.027","article-title":"Pharmacological inhibition of receptor protein tyrosine phosphatase beta\/zeta (PTPRZ1) modulates behavioral responses to ethanol","volume":"137","author":"Fernandez-Calle","year":"2018","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1007\/s13311-019-00795-4_bib107","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jnc.13252","article-title":"Ethanol activates midkine and anaplastic lymphoma kinase signaling in neuroblastoma cells and in the brain","volume":"135","author":"He","year":"2015","journal-title":"J Neurochem"},{"issue":"7","key":"10.1007\/s13311-019-00795-4_bib108","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/gbb.12384","article-title":"Midkine in the mouse ventral tegmental area limits ethanol intake and Ccl2 gene expression","volume":"16","author":"Chen","year":"2017","journal-title":"Genes Brain Behav"},{"key":"10.1007\/s13311-019-00795-4_bib109","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbr.2014.08.023","article-title":"Genetic inactivation of midkine modulates behavioural responses to ethanol possibly by enhancing GABA(A) receptor sensitivity to GABA(A) acting drugs","volume":"274","author":"Vicente-Rodriguez","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1007\/s13311-019-00795-4_bib110","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejmech.2017.11.080","article-title":"Development of inhibitors of receptor protein tyrosine phosphatase beta\/zeta (PTPRZ1) as candidates for CNS disorders","volume":"144","author":"Pastor","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1007\/s13311-019-00795-4_bib111","doi-asserted-by":"crossref","unstructured":"Fernandez-Calle, R., et al., Inhibition of RPTPbeta\/zeta blocks ethanol-induced conditioned place preference in pleiotrophin knockout mice. Behav Brain Res, 2019: p. 111933.","DOI":"10.1016\/j.bbr.2019.111933"},{"issue":"3","key":"10.1007\/s13311-019-00795-4_bib112","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"issue":"1","key":"10.1007\/s13311-019-00795-4_bib113","first-page":"240","article-title":"Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells","volume":"12","author":"Ornitz","year":"1992","journal-title":"Mol Cell Biol"},{"issue":"5013","key":"10.1007\/s13311-019-00795-4_bib114","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1126\/science.1646484","article-title":"Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation","volume":"252","author":"Rapraeger","year":"1991","journal-title":"Science"},{"issue":"6","key":"10.1007\/s13311-019-00795-4_bib115","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0092-8674(94)90032-9","article-title":"Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation","volume":"79","author":"Spivak-Kroizman","year":"1994","journal-title":"Cell"},{"issue":"4","key":"10.1007\/s13311-019-00795-4_bib116","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0092-8674(91)90512-W","article-title":"Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor","volume":"64","author":"Yayon","year":"1991","journal-title":"Cell"},{"issue":"7","key":"10.1007\/s13311-019-00795-4_bib117","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/S0021-9258(19)41631-1","article-title":"Purification of a fibroblast growth factor from bovine pituitary","volume":"250","author":"Gospodarowicz","year":"1975","journal-title":"J Biol Chem"},{"issue":"15","key":"10.1007\/s13311-019-00795-4_bib118","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1093\/emboj\/17.15.4213","article-title":"Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice","volume":"17","author":"Dono","year":"1998","journal-title":"EMBO J"},{"issue":"6","key":"10.1007\/s13311-019-00795-4_bib119","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/j.seminoncol.2015.09.027","article-title":"Fibroblast growth factor (FGF) receptor\/FGF inhibitors: novel targets and strategies for optimization of response of solid tumors","volume":"42","author":"Hierro","year":"2015","journal-title":"Semin Oncol"},{"issue":"12","key":"10.1007\/s13311-019-00795-4_bib120","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.tips.2016.10.003","article-title":"Therapeutics targeting FGF signaling network in human diseases","volume":"37","author":"Katoh","year":"2016","journal-title":"Trends Pharmacol Sci"},{"issue":"5686","key":"10.1007\/s13311-019-00795-4_bib121","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/276409a0","article-title":"Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro","volume":"276","author":"Carpenter","year":"1978","journal-title":"Nature"},{"key":"10.1007\/s13311-019-00795-4_bib122","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.phrs.2018.11.014","article-title":"Small molecule inhibitors targeting the EGFR\/ErbB family of protein-tyrosine kinases in human cancers","volume":"139","author":"Roskoski","year":"2019","journal-title":"Pharmacol Res"},{"issue":"5221","key":"10.1007\/s13311-019-00795-4_bib123","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1126\/science.7618084","article-title":"Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype","volume":"269","author":"Threadgill","year":"1995","journal-title":"Science"},{"issue":"1","key":"10.1007\/s13311-019-00795-4_bib124","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0301-0082(96)00046-9","article-title":"The neurotrophic action and signalling of epidermal growth factor","volume":"51","author":"Yamada","year":"1997","journal-title":"Prog Neurobiol"},{"issue":"12","key":"10.1007\/s13311-019-00795-4_bib125","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1093\/hmg\/ddq112","article-title":"A systematic gene-based screen of chr4q22-q32 identifies association of a novel susceptibility gene, DKK2, with the quantitative trait of alcohol dependence symptom counts","volume":"19","author":"Kalsi","year":"2010","journal-title":"Hum Mol Genet"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00795-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-019-00795-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923013740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923013740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00795-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:01:35Z","timestamp":1761807695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923013740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1878747923013740"],"URL":"https:\/\/doi.org\/10.1007\/s13311-019-00795-4","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-019-00795-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}